Risk Stratification Value of Biomarkers in Patients With Ventricular Arrhythmias

Not yet recruitingOBSERVATIONAL
Enrollment

5,000

Participants

Timeline

Start Date

December 31, 2024

Primary Completion Date

March 1, 2027

Study Completion Date

May 31, 2027

Conditions
Ventricular Arrythmia
Interventions
OTHER

Observational; No Interventions were given.

Observational; No Interventions were given.

Trial Locations (1)

710061

First Affiliated Hospital of Xian Jiantong University, Xi'an

All Listed Sponsors
collaborator

521 Hospital of NORINCO Group

OTHER

collaborator

Shaanxi Provincial People's Hospital

OTHER

collaborator

Xiangyang Central Hospital

OTHER

collaborator

Henan Provincial People's Hospital

OTHER

lead

First Affiliated Hospital Xi'an Jiaotong University

OTHER

NCT05965375 - Risk Stratification Value of Biomarkers in Patients With Ventricular Arrhythmias | Biotech Hunter | Biotech Hunter